查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386408

临床前体内影像市场报告：2030 年趋势、预测与竞争分析

Preclinical In-Vivo Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床前体内影像的趋势与预测

到 2030 年，全球临床前体内影像市场预计将达到 14 亿美元，2024 年至 2030 年复合年增长率为 6.2%。该市场的主要驱动因素是慢性病盛行率的增加、对侵入性小动物成像技术的需求不断增长以及临床前研究活动资金的增加。全球临床前体内影像市场的未来充满希望，研发和药物研发市场充满机会。

临床前体内成像市场洞察

Lucintel 预测，微超音波系统将在预测期内达到最高成长。

由于越来越多地采用研究和药物研发模式，研究和开发仍然是市场中最大的部分。

由于加拿大临床前研究量的增加以及政府对研究和创新的资助的增加，北美仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球临床前体内影像市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球临床前体内影像市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球临床前体内影像市场
    • 光学成像
    • 核子造影
    • MRI显影剂
    • 超音波显影剂
    • CT显影剂
  • 按模式分類的全球临床前体内影像市场
    • 光学成像系统
    • 临床前核子造影系统
    • 微型核磁共振系统
    • 微超音波系统
    • 显微CT系统
    • 临床前光声成像系统
    • 临床前磁粒子成像 (MPI) 系统
  • 按应用分類的全球临床前体内影像市场
    • 研究与开发
    • 药物研发
  • 按配销通路分類的全球临床前体内影像市场
    • 製药公司
    • 生技公司
    • 研究机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球临床前体内影像市场（按地区）
  • 北美临床前体内影像市场
  • 欧洲临床前体内影像市场
  • 亚太地区临床前体内影像市场
  • 其他区域临床前体内影像市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球临床前体内成像市场成长机会
    • 按方式分類的全球临床前体内影像市场成长机会
    • 全球临床前体内影像市场成长机会（按应用）
    • 按配销通路分類的全球临床前体内成像市场成长机会
    • 按地区分類的全球临床前体内成像市场成长机会
  • 全球临床前体内影像市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球临床前体内影像市场的能力
    • 全球临床前体内影像市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Bruker Corporation
  • Siemens
  • TriFoil Imaging
  • PerkinElmer
  • VisualSonics
简介目录

Preclinical In-Vivo Imaging Trends and Forecast

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

A more than 150-page report is developed to help in your business decisions.

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Optical Imaging
  • Nuclear Imaging
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Optical Imaging Systems
  • Preclinical Nuclear Imaging Systems
  • Micro-MRI Systems
  • Micro-Ultrasound Systems
  • Micro-CT Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Development
  • Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Others

Preclinical In-Vivo Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preclinical in-vivo imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

  • Bruker Corporation
  • Siemens
  • Trifoil Imaging
  • Perkinelmer
  • Visualsonics

Preclinical In-Vivo Imaging Market Insights

Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Within this market, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.

North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Features of the Global Preclinical In-Vivo Imaging Market

Market Size Estimates: Preclinical in-vivo imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the preclinical in-vivo imaging market size?

Answer: The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for preclinical in-vivo imaging market?

Answer: The global preclinical in-vivo imaging market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the preclinical in-vivo imaging market?

Answer: The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

Q4. What are the major segments for preclinical in-vivo imaging market?

Answer: The future of the preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets.

Q5. Who are the key preclinical in-vivo imaging market companies?

Answer: Some of the key preclinical in-vivo imaging companies are as follows:

  • Bruker Corporation
  • Siemens
  • TriFoil Imaging
  • PerkinElmer
  • VisualSonics

Q6. Which preclinical in-vivo imaging market segment will be the largest in future?

Answer: Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Q7. In preclinical in-vivo imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preclinical In-Vivo Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Preclinical In-Vivo Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Preclinical In-Vivo Imaging Market by Type
    • 3.3.1: Optical Imaging
    • 3.3.2: Nuclear Imaging
    • 3.3.3: MRI Contrast Agents
    • 3.3.4: Ultrasound Contrast Agents
    • 3.3.5: CT Contrast Agents
  • 3.4: Global Preclinical In-Vivo Imaging Market by Modality
    • 3.4.1: Optical Imaging Systems
    • 3.4.2: Preclinical Nuclear Imaging Systems
    • 3.4.3: Micro-MRI Systems
    • 3.4.4: Micro-Ultrasound Systems
    • 3.4.5: Micro-CT Systems
    • 3.4.6: Preclinical Photoacoustic Imaging Systems
    • 3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
  • 3.5: Global Preclinical In-Vivo Imaging Market by Application
    • 3.5.1: Research & Development
    • 3.5.2: Drug Discovery
  • 3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
    • 3.6.1: Pharmaceutical Companies
    • 3.6.2: Biotechnology Companies
    • 3.6.3: Research Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Preclinical In-Vivo Imaging Market by Region
  • 4.2: North American Preclinical In-Vivo Imaging Market
    • 4.2.1: North American Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.2.2: North American Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.3: European Preclinical In-Vivo Imaging Market
    • 4.3.1: European Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.3.2: European Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.4: APAC Preclinical In-Vivo Imaging Market
    • 4.4.1: APAC Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.4.2: APAC Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
  • 4.5: ROW Preclinical In-Vivo Imaging Market
    • 4.5.1: ROW Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
    • 4.5.2: ROW Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
    • 6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
    • 6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
    • 6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
  • 6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bruker Corporation
  • 7.2: Siemens
  • 7.3: TriFoil Imaging
  • 7.4: PerkinElmer
  • 7.5: VisualSonics